FILTER

LATEST INTERVIEWS

Dr. Andrea Pfeifer

CO-FOUNDER & CEO, AC IMMUNE
AC Immune describes its research into neurodegenerative diseases.

Mark Egerton

CEO, QUOTIENT SCIENCES
Quotient Sciences is a drug development and manufacturing accelerator that supports pharmaceutical and biotech companies with services spanning the entire development pathway from candidate selection to commercial launch.

Theo Yameogo

CO-LEADER – MINING AND METALS, ERNST & YOUNG LLP
EY explains how mining is undergoing a transition driven by technology and a clear focus on ESG.

Tom Juric

DIVISIONAL DIRECTOR – MINING, LIEBHERR CANADA
Liebherr explains how it is attempting to build up is share of the Canadian mining equipment market.

Laurent Nataf

CEO & PRESIDENT ASIA PACIFIC, AZELIS
Azelis is developing Singapore as a financial and logistics hub for all activities in the Asia Pacific region.

Roger Marchioni

ASIA DIRECTOR, CHEMICALS AND POLYMERS, BRASKEM
Braskem speaks to GBR about the goals of its Singapore office.

Jay Shukla

PRESIDENT & CEO, NIVAGEN PHARMACEUTICALS, INC.
Nivagen Pharmaceuticals provides complete research, analytical formulation development, and regulatory support.

Dr. Jagadeesh Babu Rangisetty

FOUNDER & CEO, BIOPHORE
Biophore explains how it is expanding productions of different APIs to ensure both quality and supply chain security.

Dirk Lorenz-Meyer

MEMBER OF THE BOARD, BEHN MEYER GROUP
Behn Meyer Group speaks to GBR about its business in Singapore and SE Asia.

Wim Roels

CEO, BOROUGE
Borouge speaks to GBR about trends affecting its polyethylene and polypropylene solutions business.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

USA Mining 2025-26 - Pre-release

USA Mining 2025-26 pre-release is a snapshot capturing insights from over 70 executives and decision-makers across the value chain and from coast to coast, sharing not only how the industry is changing, but also where it is heading next.

PARTNER EVENTS